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Consultations for infantile hypercalcaemia (IIH) have
increased at Sydney Children’s Hospital since guidelines
for vitamin D3 supplementation during pregnancy were
introduced in 2006. Recent nationwide shortages of low-
calcium formula (LCF) suggest this problem may be
widespread. CYP24A1 mutations have been identified as
a potential cause of IIH.
To determine if IIH is occurring more commonly, de-
identified, first-measured serum calcium from all infants
<6 months (n=5796) measured in our laboratory, were
grouped by years 2005-2007 (n=1516), 2008-2010
(n=1945) and 2011-2013 (n=2335). In addition, we ana-
lysed 13 infants treated by our department for idiopathic
infantile hypercalcaemia (IIH) from 2011-2013.
Rates of hypercalcaemia (>2.75mmol/L) increased
from 2011 (1.1% vs 1.3% vs 8.7%, c2P<0.001). Rates of
hypocalcaemia (<2.25mmol/L) fell steadily (42.4% vs
32.3% vs 24.8% %, c2P<0.001). Twelve mothers of our
13 infants with IIH received antenatal vitamin D3 sup-
plementation. One infant also received 400 units/day
Vitamin D3 post-natally. At diagnosis, median age was
13 days (range 4-50), 77% were breast-fed, 54% were
symptomatic and 25% had nephrocalcinosis. Median
initial calcium was 3.00mmol/L (range 2.84-4.03) and
phosphate 2.04mmol/L (1.1-3.33). PTH was not elevated
(median 1.0pmol/L [<0.3-3.1]), urinary calcium: creati-
nine ratio not suppressed (median 2.3, [0.4-9]),
25OHVitD low-normal (median 44nmol/L [17-218]) and
1,25(OH)2VitD elevated (median 232pmol/L [64-720]),
in keeping with an abnormality in CYP24A1. In 7/10
infants with data available, treated with LCF for median
95 days (range 25-310), median PTH rose to 17.1pmol/L
([8.2-49.3], P=0.02) with a trend to lower 25OHVit D
(median 23nmol/L [<10-108], P=0.09) despite continued
high-normal calcium levels (median 2.66mmol/L [2.11-
2.75]).
Concurrent changes in rates of hyper and hypo-calcae-
mia suggest antenatal vitamin D3 supplementation as an
aetiological factor. IIH was associated with significant
morbidity, including symptomatic hypercalcaemia and
nephrocalcinosis. Treatment with LCF prevented further
symptomatic hypercalcaemia, but resulted in elevated
PTH. The biochemistry of our patients with IIH raises
variations in Vitamin D metabolism or calcium set-point
as potential associated factors.
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